Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization.
about
Dry age-related macular degeneration: A currently unmet clinical need.Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?Phosphatidylserine (PS) Is Exposed in Choroidal Neovascular Endothelium: PS-Targeting Antibodies Inhibit Choroidal Angiogenesis In Vivo and Ex VivoThe alternative complement pathway propagates inflammation and injury in murine ischemic strokeProgress and Trends in Complement TherapeuticsComplement in immune and inflammatory disorders: therapeutic interventions.Detection of complement activation using monoclonal antibodies against C3d.New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities.Rational engineering of a minimized immune inhibitor with unique triple-targeting properties.Aging is not a disease: distinguishing age-related macular degeneration from aging.C3a Increases VEGF and Decreases PEDF mRNA Levels in Human Retinal Pigment Epithelial CellsPreliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration.Novel evidence for complement system activation in chick myopia and hyperopia models: a meta-analysis of transcriptome datasets.Alkylglycerols reduce serum complement and plasma vascular endothelial growth factor in obese individuals.Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy.Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization.Complement factor H in AMD: Bridging genetic associations and pathobiology.Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation.Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model.
P2860
Q34378033-E1BF1EF1-047B-41B5-9536-5D9BCC353237Q35118257-83B0ED50-8BA8-4401-AB47-C71A256F47F8Q35633511-E63E83E2-F046-466C-A439-61A5F17E0376Q35750545-A8F57A4D-603F-44FC-B5B3-DE6B7BCAA137Q35830423-73538507-BF85-4009-8A4E-FFA3F17AEF7AQ36339354-01CC9DE9-42F0-47AC-882E-DE59D49CE1DBQ36479278-7DACA6E9-FC0E-4820-8467-C5DE40CF4B38Q36756854-65DCCC8A-343E-491B-B404-D0C83DC455D6Q36793448-69443A78-E711-4F6A-A641-4027D60281A3Q37180522-90AB9DFE-5447-48A3-B736-9E8C21F2CDB9Q37300691-4770D37C-F125-4DBF-8B74-AA94C7B2AE9FQ37315838-2A524332-7CB5-425B-B532-A1DFF1E4EA4BQ37322563-8EFB1B85-3102-46EA-8C54-4A91ACF85761Q37361488-91B1E3C6-57B3-454B-8750-5758D7A982C1Q38602976-0AACEB57-B839-42E6-B33C-3760C6622D4AQ39759133-B6E3CE25-5428-4CAC-8595-11B7FC9530C1Q40865063-AC828A2B-FC4B-4F18-B80B-CC710C0523F0Q45875770-98975781-853A-46E9-93DA-8D5AE2B34577Q46022690-3734F2B5-73A7-42F8-BF6E-BA0C9447D06AQ49509910-0F764051-C982-4607-B87C-B92027105185Q52724247-25202C1A-B547-49E0-9579-1C16AB59C6EE
P2860
Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Systemic human CR2-targeted co ...... choroidal neovascularization.
@ast
Systemic human CR2-targeted co ...... choroidal neovascularization.
@en
Systemic human CR2-targeted co ...... choroidal neovascularization.
@nl
type
label
Systemic human CR2-targeted co ...... choroidal neovascularization.
@ast
Systemic human CR2-targeted co ...... choroidal neovascularization.
@en
Systemic human CR2-targeted co ...... choroidal neovascularization.
@nl
prefLabel
Systemic human CR2-targeted co ...... choroidal neovascularization.
@ast
Systemic human CR2-targeted co ...... choroidal neovascularization.
@en
Systemic human CR2-targeted co ...... choroidal neovascularization.
@nl
P2093
P2860
P356
P1476
Systemic human CR2-targeted co ...... choroidal neovascularization.
@en
P2093
Beth Coughlin
Bärbel Rohrer
Mausumi Bandyopadhyay
V Michael Holers
P2860
P304
P356
10.1089/JOP.2011.0212
P577
2012-02-06T00:00:00Z